<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0"><channel><title>The Janus Pharma Insights</title><link>https://janus.co.in/</link><description><![CDATA[The Janus Pharma Insights is a podcast by Janus Biotech focused on India’s evolving pharmaceutical and healthcare industry. From pharmaceutical manufacturing, PCD pharma franchise, and third-party manufacturing to skincare, nutraceuticals, healthcare innovation, and pharma business growth — this podcast explores the ideas, trends, and strategies shaping the future of the pharma sector.<br /><br />Each episode brings practical discussions, industry insights, manufacturing knowledge, and healthcare business conversations designed for pharma professionals, distributors, healthcare entrepreneurs, and growing pharmaceutical brands.Powered by Janus Biotech, this podcast shares trusted pharmaceutical industry insights backed by years of experience in India’s healthcare and pharma manufacturing ecosystem.<br /><br />Explore more at <b><a href="https://janus.co.in/" target="_blank" rel="noreferrer noopener">Janus Biotech</a></b>.]]></description><atom:link href="https://www.spreaker.com/show/6988873/episodes/feed" rel="self" type="application/rss+xml"/><language>en</language><category>Nutrition</category><copyright>Janus Biotech</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg</url><title>The Janus Pharma Insights</title><link>https://janus.co.in/</link></image><lastBuildDate>Wed, 12 Aug 2026 07:36:46 +0000</lastBuildDate><itunes:author>Rohit Mehmi</itunes:author><itunes:owner><itunes:name>Janus Biotech</itunes:name><itunes:email>janusbiotech12@gmail.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg"/><itunes:subtitle>The Janus Pharma Insights is a podcast by Janus Biotech focused on India’s evolving pharmaceutical and healthcare industry. From pharmaceutical manufacturing, PCD pharma franchise, and third-party manufacturing to skincare, nutraceuticals, healthcare...</itunes:subtitle><itunes:summary><![CDATA[The Janus Pharma Insights is a podcast by Janus Biotech focused on India’s evolving pharmaceutical and healthcare industry. From pharmaceutical manufacturing, PCD pharma franchise, and third-party manufacturing to skincare, nutraceuticals, healthcare innovation, and pharma business growth — this podcast explores the ideas, trends, and strategies shaping the future of the pharma sector.<br /><br />Each episode brings practical discussions, industry insights, manufacturing knowledge, and healthcare business conversations designed for pharma professionals, distributors, healthcare entrepreneurs, and growing pharmaceutical brands.Powered by Janus Biotech, this podcast shares trusted pharmaceutical industry insights backed by years of experience in India’s healthcare and pharma manufacturing ecosystem.<br /><br />Explore more at <b><a href="https://janus.co.in/" target="_blank" rel="noreferrer noopener">Janus Biotech</a></b>.]]></itunes:summary><itunes:category text="Health &amp; Fitness"><itunes:category text="Nutrition"/></itunes:category><itunes:category text="Arts"><itunes:category text="Food"/></itunes:category><itunes:category text="Health &amp; Fitness"/><itunes:explicit>false</itunes:explicit><podcast:guid>dc040e07-375d-5e57-8cd7-fc0e57857112</podcast:guid><itunes:type>episodic</itunes:type><item><title>Where Is Vonoprazan Headed The 2027 Outlook for PCD Franchise Partners</title><link>https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/</link><description><![CDATA[Episode 8. India's GERD market is projected to reach ₹2,245 crore by 2033, and Vonoprazan is capturing a growing share of it — backed by Torrent, Lupin, Dr Reddy's, Zydus, and Mankind all launching their own brands. This episode covers the <a href="https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/" target="_blank" rel="noreferrer noopener">future of Vonoprazan PCD pharma business in India</a> through 2027 — falling prices, growing combination products, and why tier-2 and tier-3 cities are where the real opportunity lies for franchise partners right now. Also explore <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">Janus Biotech's Vonoprazan PCD, HP kit and Domperidone guide</a> and the <a href="https://janus.co.in/product/vonoprazan-20-mg-10mg/" target="_blank" rel="noreferrer noopener">Vonoprazan 10mg and 20mg product range</a>. Earlier episodes covered <a href="https://www.spreaker.com/episode/janus-biotech-one-company-17-divisions-3500-products--73276600" target="_blank" rel="noreferrer noopener">Janus Biotech as a company</a>, <a href="https://www.spreaker.com/episode/is-vonoprazan-pcd-the-right-franchise-for-you-janus-biotech--72853089" target="_blank" rel="noreferrer noopener">whether Vonoprazan PCD is right for you</a>, <a href="https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263" target="_blank" rel="noreferrer noopener">HP kit and Domperidone combinations</a>, <a href="https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD opportunity</a>, <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a treatment</a>, and <a href="https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452" target="_blank" rel="noreferrer noopener">the rise of niacinamide serum manufacturing</a>. 👉 <a href="https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/" target="_blank" rel="noreferrer noopener">https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/73837350</guid><pubDate>Wed, 12 Aug 2026 07:19:42 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/73837350/where_is_vonoprazan_headed_the_2027_outlook_for_pcd_franchise_partners.mp3" length="23303033" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/73ee68d2-4f40-4215-a39b-a975729af596/73ee68d2-4f40-4215-a39b-a975729af596.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/73ee68d2-4f40-4215-a39b-a975729af596/73ee68d2-4f40-4215-a39b-a975729af596.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/73ee68d2-4f40-4215-a39b-a975729af596/73ee68d2-4f40-4215-a39b-a975729af596.vtt" type="text/vtt" language="en"/><itunes:author>Rohit Mehmi</itunes:author><itunes:subtitle>Episode 8. India's GERD market is projected to reach ₹2,245 crore by 2033, and Vonoprazan is capturing a growing share of it — backed by Torrent, Lupin, Dr Reddy's, Zydus, and Mankind all launching their own brands. This episode covers the...</itunes:subtitle><itunes:summary><![CDATA[Episode 8. India's GERD market is projected to reach ₹2,245 crore by 2033, and Vonoprazan is capturing a growing share of it — backed by Torrent, Lupin, Dr Reddy's, Zydus, and Mankind all launching their own brands. This episode covers the <a href="https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/" target="_blank" rel="noreferrer noopener">future of Vonoprazan PCD pharma business in India</a> through 2027 — falling prices, growing combination products, and why tier-2 and tier-3 cities are where the real opportunity lies for franchise partners right now. Also explore <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">Janus Biotech's Vonoprazan PCD, HP kit and Domperidone guide</a> and the <a href="https://janus.co.in/product/vonoprazan-20-mg-10mg/" target="_blank" rel="noreferrer noopener">Vonoprazan 10mg and 20mg product range</a>. Earlier episodes covered <a href="https://www.spreaker.com/episode/janus-biotech-one-company-17-divisions-3500-products--73276600" target="_blank" rel="noreferrer noopener">Janus Biotech as a company</a>, <a href="https://www.spreaker.com/episode/is-vonoprazan-pcd-the-right-franchise-for-you-janus-biotech--72853089" target="_blank" rel="noreferrer noopener">whether Vonoprazan PCD is right for you</a>, <a href="https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263" target="_blank" rel="noreferrer noopener">HP kit and Domperidone combinations</a>, <a href="https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD opportunity</a>, <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a treatment</a>, and <a href="https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452" target="_blank" rel="noreferrer noopener">the rise of niacinamide serum manufacturing</a>. 👉 <a href="https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/" target="_blank" rel="noreferrer noopener">https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/</a>]]></itunes:summary><itunes:duration>1457</itunes:duration><itunes:keywords>acidrefluxtreatment,gastrofranchise,gerdmarket,janusbiotech,pcdpharmafranchise,pharmafranchiseindia,vonoprazanfranchise,vonoprazanfuture,vonoprazanindia,vonoprazanpcd2027</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Janus Biotech One Company, 17 Divisions, 3500+ Products</title><link>https://janus.co.in/</link><description><![CDATA[Episode 7. Six episodes in and we've been deep in Vonoprazan — today we step back and look at <a href="https://janus.co.in/" target="_blank" rel="noreferrer noopener">Janus Biotech</a> as a whole. From a single pharmacy in 1957 to one of North India's fastest growing pharma companies, with 3500+ products, 1500+ business partners, and 17 specialized divisions covering gastro, cardiac, gynecology, derma, pediatrics, nutraceuticals, orthopedics and more. This episode covers what that range means for franchise partners and why a multi-division company changes the math on long-term business growth. Explore <a href="https://janus.co.in/pcd-pharma-franchise/" target="_blank" rel="noreferrer noopener">ethical monopoly marketing and PCD franchise</a>, <a href="https://janus.co.in/third-party-manufacturing/" target="_blank" rel="noreferrer noopener">contract manufacturing</a>, and the <a href="https://janus.co.in/product-category/products/" target="_blank" rel="noreferrer noopener">full product range</a> at Janus Biotech. Earlier episodes covered <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a treatment</a>, <a href="https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD opportunity</a>, <a href="https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263" target="_blank" rel="noreferrer noopener">HP kit and Domperidone combinations</a>, <a href="https://www.spreaker.com/episode/is-vonoprazan-pcd-the-right-franchise-for-you-janus-biotech--72853089" target="_blank" rel="noreferrer noopener">whether Vonoprazan PCD is right for you</a>, and <a href="https://www.spreaker.com/episode/what-s-next-for-vonoprazan-pcd-india-s-gerd-market-through-2027--73275456" target="_blank" rel="noreferrer noopener">India's GERD market through 2027</a>.<br />👉 <a href="https://janus.co.in/" target="_blank" rel="noreferrer noopener">https://janus.co.in/</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/73476314</guid><pubDate>Wed, 05 Aug 2026 05:38:00 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/73476314/janus_biotech_one_company_17_divisions_3500_products.mp3" length="19152698" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/5f9757be-827a-4bff-b06d-d0bbc35bedef/5f9757be-827a-4bff-b06d-d0bbc35bedef.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/5f9757be-827a-4bff-b06d-d0bbc35bedef/5f9757be-827a-4bff-b06d-d0bbc35bedef.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/5f9757be-827a-4bff-b06d-d0bbc35bedef/5f9757be-827a-4bff-b06d-d0bbc35bedef.vtt" type="text/vtt" language="en"/><itunes:author>Rohit Mehmi</itunes:author><itunes:subtitle>Episode 7. Six episodes in and we've been deep in Vonoprazan — today we step back and look at https://janus.co.in/ as a whole. From a single pharmacy in 1957 to one of North India's fastest growing pharma companies, with 3500+ products, 1500+ business...</itunes:subtitle><itunes:summary><![CDATA[Episode 7. Six episodes in and we've been deep in Vonoprazan — today we step back and look at <a href="https://janus.co.in/" target="_blank" rel="noreferrer noopener">Janus Biotech</a> as a whole. From a single pharmacy in 1957 to one of North India's fastest growing pharma companies, with 3500+ products, 1500+ business partners, and 17 specialized divisions covering gastro, cardiac, gynecology, derma, pediatrics, nutraceuticals, orthopedics and more. This episode covers what that range means for franchise partners and why a multi-division company changes the math on long-term business growth. Explore <a href="https://janus.co.in/pcd-pharma-franchise/" target="_blank" rel="noreferrer noopener">ethical monopoly marketing and PCD franchise</a>, <a href="https://janus.co.in/third-party-manufacturing/" target="_blank" rel="noreferrer noopener">contract manufacturing</a>, and the <a href="https://janus.co.in/product-category/products/" target="_blank" rel="noreferrer noopener">full product range</a> at Janus Biotech. Earlier episodes covered <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a treatment</a>, <a href="https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD opportunity</a>, <a href="https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263" target="_blank" rel="noreferrer noopener">HP kit and Domperidone combinations</a>, <a href="https://www.spreaker.com/episode/is-vonoprazan-pcd-the-right-franchise-for-you-janus-biotech--72853089" target="_blank" rel="noreferrer noopener">whether Vonoprazan PCD is right for you</a>, and <a href="https://www.spreaker.com/episode/what-s-next-for-vonoprazan-pcd-india-s-gerd-market-through-2027--73275456" target="_blank" rel="noreferrer noopener">India's GERD market through 2027</a>.<br />👉 <a href="https://janus.co.in/" target="_blank" rel="noreferrer noopener">https://janus.co.in/</a>]]></itunes:summary><itunes:duration>1197</itunes:duration><itunes:keywords>3500products,contractmanufacturing,gastrofranchise,janusbiotech,monopolyrights,multiplefranchisedivisions,northindiapharma,pcdpharmafranchise,pharmacompanyindia,pharmafranchiseindia</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>What's Next for Vonoprazan PCD India's GERD Market Through 2027</title><link>https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/</link><description><![CDATA[Vonoprazan is reshaping how India treats acid reflux, working faster and controlling night-time acid breakthrough better than older PPIs like pantoprazole or omeprazole — which is why major players from Torrent to Mankind have launched their own versions within months of each other. In this episode, we look at where the Vonoprazan PCD opportunity is headed through 2027, from falling prices as exclusivity fades to the rise of H. pylori combination products, and why tier 2 and tier 3 cities are set to drive most of the growth. This continues what we've built up in earlier episodes — starting with <a href="https://www.spreaker.com/cms/shows/6988873/EP1_URL" target="_blank" rel="noreferrer noopener">what makes Vonoprazan the next-gen acid reflux treatment</a>, then <a href="https://www.spreaker.com/cms/shows/6988873/EP2_URL" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD opportunity nobody's talking about</a>, <a href="https://www.spreaker.com/cms/shows/6988873/EP3_URL" target="_blank" rel="noreferrer noopener">the Vonoprazan HP kit and Domperidone combination</a>, and <a href="https://www.spreaker.com/cms/shows/6988873/EP4_URL" target="_blank" rel="noreferrer noopener">whether Vonoprazan PCD is the right franchise for you</a>. For the full market breakdown behind this episode, read <a href="https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/" target="_blank" rel="noreferrer noopener">Janus Biotech's guide to the future of Vonoprazan PCD pharma business in India</a>.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/73275456</guid><pubDate>Fri, 31 Jul 2026 07:34:11 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/73275456/what_s_next_for_vonoprazan_pcd_india_s_gerd_market_through_2027.mp3" length="20395709" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/1963cf20-2813-4deb-9a10-014842fb7ca6/1963cf20-2813-4deb-9a10-014842fb7ca6.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/1963cf20-2813-4deb-9a10-014842fb7ca6/1963cf20-2813-4deb-9a10-014842fb7ca6.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/1963cf20-2813-4deb-9a10-014842fb7ca6/1963cf20-2813-4deb-9a10-014842fb7ca6.vtt" type="text/vtt" language="en"/><itunes:author>Rohit Mehmi</itunes:author><itunes:subtitle>Vonoprazan is reshaping how India treats acid reflux, working faster and controlling night-time acid breakthrough better than older PPIs like pantoprazole or omeprazole — which is why major players from Torrent to Mankind have launched their own...</itunes:subtitle><itunes:summary><![CDATA[Vonoprazan is reshaping how India treats acid reflux, working faster and controlling night-time acid breakthrough better than older PPIs like pantoprazole or omeprazole — which is why major players from Torrent to Mankind have launched their own versions within months of each other. In this episode, we look at where the Vonoprazan PCD opportunity is headed through 2027, from falling prices as exclusivity fades to the rise of H. pylori combination products, and why tier 2 and tier 3 cities are set to drive most of the growth. This continues what we've built up in earlier episodes — starting with <a href="https://www.spreaker.com/cms/shows/6988873/EP1_URL" target="_blank" rel="noreferrer noopener">what makes Vonoprazan the next-gen acid reflux treatment</a>, then <a href="https://www.spreaker.com/cms/shows/6988873/EP2_URL" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD opportunity nobody's talking about</a>, <a href="https://www.spreaker.com/cms/shows/6988873/EP3_URL" target="_blank" rel="noreferrer noopener">the Vonoprazan HP kit and Domperidone combination</a>, and <a href="https://www.spreaker.com/cms/shows/6988873/EP4_URL" target="_blank" rel="noreferrer noopener">whether Vonoprazan PCD is the right franchise for you</a>. For the full market breakdown behind this episode, read <a href="https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/" target="_blank" rel="noreferrer noopener">Janus Biotech's guide to the future of Vonoprazan PCD pharma business in India</a>.]]></itunes:summary><itunes:duration>1275</itunes:duration><itunes:keywords>gastropcdfranchise,gerdmarketindia,janusbiotech,pcabacidreflux,pcdpharmabusiness,pharmafranchiseindia,vonoprazanhpkit,vonoprazanpcd,vonoprazanpharmafranchise,whogmppharmafranchise</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Is Vonoprazan PCD the Right Franchise for You</title><link>https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/</link><description><![CDATA[Episode 5. Vonoprazan PCD franchise is gaining traction — but is it the right move for your business? This episode breaks down the honest case: chronic repeat prescriptions, early mover advantage in a growing category, and a versatile product range covering GERD, nausea, and H. pylori eradication. Full details in <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">Janus Biotech's Vonoprazan PCD, HP kit and Domperidone guide</a>. If you're just joining us, Episode 2 covered <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a next-gen acid reflux treatment</a>, Episode 3 broke down <a href="https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD opportunity</a>, and Episode 4 explored <a href="https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263" target="_blank" rel="noreferrer noopener">the HP kit and Domperidone combinations</a>. Episode 1 covered <a href="https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452" target="_blank" rel="noreferrer noopener">the rise of niacinamide serum manufacturing in India</a>. <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/73139111</guid><pubDate>Fri, 24 Jul 2026 05:43:23 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/73139111/is_vonoprazan_pcd_the_right_franchise_for_you.mp3" length="19326151" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/e21dda65-448a-4088-abf3-509084397e61/e21dda65-448a-4088-abf3-509084397e61.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/e21dda65-448a-4088-abf3-509084397e61/e21dda65-448a-4088-abf3-509084397e61.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/e21dda65-448a-4088-abf3-509084397e61/e21dda65-448a-4088-abf3-509084397e61.vtt" type="text/vtt" language="en"/><itunes:author>Rohit Mehmi</itunes:author><itunes:subtitle>Episode 5. Vonoprazan PCD franchise is gaining traction — but is it the right move for your business? This episode breaks down the honest case: chronic repeat prescriptions, early mover advantage in a growing category, and a versatile product range...</itunes:subtitle><itunes:summary><![CDATA[Episode 5. Vonoprazan PCD franchise is gaining traction — but is it the right move for your business? This episode breaks down the honest case: chronic repeat prescriptions, early mover advantage in a growing category, and a versatile product range covering GERD, nausea, and H. pylori eradication. Full details in <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">Janus Biotech's Vonoprazan PCD, HP kit and Domperidone guide</a>. If you're just joining us, Episode 2 covered <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a next-gen acid reflux treatment</a>, Episode 3 broke down <a href="https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD opportunity</a>, and Episode 4 explored <a href="https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263" target="_blank" rel="noreferrer noopener">the HP kit and Domperidone combinations</a>. Episode 1 covered <a href="https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452" target="_blank" rel="noreferrer noopener">the rise of niacinamide serum manufacturing in India</a>. <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/</a>]]></itunes:summary><itunes:duration>1208</itunes:duration><itunes:keywords>acidrefluxtreatment,gastrofranchise,gerdtreatment,hpkit,janusbiotech,pcdpharmafranchise,pharmafranchiseindia,vonoprazandomperidone,vonoprazanfranchise,vonoprazanpcd</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Vonoprazan HP Kit and Domperidone: The Gastro Combinations Worth Knowing</title><link>https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/</link><description><![CDATA[Episode 4. We go deeper into the Vonoprazan product range — covering two combinations that are gaining serious traction with doctors right now. The <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">Vonoprazan HP kit and Vonoprazan Domperidone guide by Janus Biotech</a> covers H. pylori eradication therapy, chronic GERD management, and why these combinations make a strong case for any gastro franchise portfolio. We also cover the <a href="https://janus.co.in/product/vonoprazan-20-mg-10mg/" target="_blank" rel="noreferrer noopener">Vonoprazan 10mg and 20mg tablet range</a> available through Janus Biotech's PCD franchise model. If you're just joining us, Episode 2 covered <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a next-gen acid reflux treatment</a> and Episode 3 broke down <a href="https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD franchise opportunity</a> in detail.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/73008668</guid><pubDate>Thu, 16 Jul 2026 06:02:36 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/73008668/vonoprazan_strategy_for_gastrointestinal_pcd_franchises.mp3" length="21062772" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/f0317259-049c-441f-a832-67912c4ad63a/f0317259-049c-441f-a832-67912c4ad63a.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/f0317259-049c-441f-a832-67912c4ad63a/f0317259-049c-441f-a832-67912c4ad63a.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/f0317259-049c-441f-a832-67912c4ad63a/f0317259-049c-441f-a832-67912c4ad63a.vtt" type="text/vtt" language="en"/><itunes:author>Rohit Mehmi</itunes:author><itunes:subtitle>Episode 4. We go deeper into the Vonoprazan product range — covering two combinations that are gaining serious traction with doctors right now. The https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/ covers H. pylori eradication therapy,...</itunes:subtitle><itunes:summary><![CDATA[Episode 4. We go deeper into the Vonoprazan product range — covering two combinations that are gaining serious traction with doctors right now. The <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">Vonoprazan HP kit and Vonoprazan Domperidone guide by Janus Biotech</a> covers H. pylori eradication therapy, chronic GERD management, and why these combinations make a strong case for any gastro franchise portfolio. We also cover the <a href="https://janus.co.in/product/vonoprazan-20-mg-10mg/" target="_blank" rel="noreferrer noopener">Vonoprazan 10mg and 20mg tablet range</a> available through Janus Biotech's PCD franchise model. If you're just joining us, Episode 2 covered <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a next-gen acid reflux treatment</a> and Episode 3 broke down <a href="https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308" target="_blank" rel="noreferrer noopener">the Vonoprazan PCD franchise opportunity</a> in detail.]]></itunes:summary><itunes:duration>1317</itunes:duration><itunes:keywords>acidsuppression,gastrofranchise,gastromedicines,gerdtreatment,hpylorieradication,janusbiotech,pcdpharmafranchise,vonoprazandomperidone,vonoprazanhpkit,vonoprazanpcd</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>The Vonoprazan PCD Opportunity Nobody's Talking About - Janus Biotech</title><link>https://janus.co.in/vonoprazan-hp-kit-uses/</link><description><![CDATA[Episode 3. Vonoprazan is already gaining ground with doctors — but the real opportunity is on the distribution side. This episode breaks down why a <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">Vonoprazan PCD</a> pharma franchise makes business sense right now, from repeat demand driven by chronic GERD patients to monopoly rights and strong profit margins. We also cover the HP kit for H. pylori therapy and the Vonoprazan Domperidone combination — two products that round out a solid gastro portfolio. You can explore <a href="https://janus.co.in/product/vonoprazan-20-mg-10mg/" target="_blank" rel="noreferrer noopener">Vonoprazan 10mg and 20mg tablets</a> directly on the Janus Biotech product page. If you missed the earlier episodes, Episode 2 covered <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a next-gen acid reflux treatment</a> and Episode 1 explored <a href="https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452" target="_blank" rel="noreferrer noopener">the rise of niacinamide serum manufacturing in India</a>.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/72851308</guid><pubDate>Tue, 07 Jul 2026 09:27:39 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/72851308/the_vonoprazan_pcd_opportunity_nobody_s_talking_about_janus_biotech.mp3" length="797087" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/67440a08-96fe-462f-a1c6-afcfaf38f54e/67440a08-96fe-462f-a1c6-afcfaf38f54e.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/67440a08-96fe-462f-a1c6-afcfaf38f54e/67440a08-96fe-462f-a1c6-afcfaf38f54e.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/67440a08-96fe-462f-a1c6-afcfaf38f54e/67440a08-96fe-462f-a1c6-afcfaf38f54e.vtt" type="text/vtt" language="en"/><itunes:author>Rohit Mehmi</itunes:author><itunes:subtitle>Episode 3. Vonoprazan is already gaining ground with doctors — but the real opportunity is on the distribution side. This episode breaks down why a https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/ pharma franchise makes business sense...</itunes:subtitle><itunes:summary><![CDATA[Episode 3. Vonoprazan is already gaining ground with doctors — but the real opportunity is on the distribution side. This episode breaks down why a <a href="https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/" target="_blank" rel="noreferrer noopener">Vonoprazan PCD</a> pharma franchise makes business sense right now, from repeat demand driven by chronic GERD patients to monopoly rights and strong profit margins. We also cover the HP kit for H. pylori therapy and the Vonoprazan Domperidone combination — two products that round out a solid gastro portfolio. You can explore <a href="https://janus.co.in/product/vonoprazan-20-mg-10mg/" target="_blank" rel="noreferrer noopener">Vonoprazan 10mg and 20mg tablets</a> directly on the Janus Biotech product page. If you missed the earlier episodes, Episode 2 covered <a href="https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491" target="_blank" rel="noreferrer noopener">Vonoprazan as a next-gen acid reflux treatment</a> and Episode 1 explored <a href="https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452" target="_blank" rel="noreferrer noopener">the rise of niacinamide serum manufacturing in India</a>.]]></itunes:summary><itunes:duration>48</itunes:duration><itunes:keywords>gastrofranchise,hpkit,janusbiotech,monopolyrights,pcdpharmafranchise,pharmafranchiseindia,vonoprazan,vonoprazandomperidone,vonoprazanfranchise,vonoprazanpcd</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Vonoprazan The Next-Gen Acid Reflux Treatment-Janus Biotech</title><link>https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491</link><description><![CDATA[In Episode 2 of The Janus Pharma Insights, we explore Vonoprazan — a potassium-competitive acid blocker (P-CAB) offering fast, lasting relief for GERD, reflux esophagitis, and peptic ulcers. We look at why it's gaining traction with healthcare providers and how Janus Biotech supplies high-grade Vonoprazan 10 mg and 20 mg tablets to distributors and pharmacies across India. Looking for a reliable supply partner? Visit janus.co.in to learn more.<br />🔗 Read more: <a href="https://janus.co.in/product/vonoprazan-20-mg-10mg/" target="_blank" rel="noreferrer noopener">https://janus.co.in/product/vonoprazan-20-mg-10mg/</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/72700491</guid><pubDate>Fri, 26 Jun 2026 10:08:35 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/72700491/vonoprazan_the_next_gen_acid_reflux_treatment_janus_biotech.mp3" length="931984" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/45a09c1f-9b5f-448f-a816-29ab31337e61/45a09c1f-9b5f-448f-a816-29ab31337e61.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/45a09c1f-9b5f-448f-a816-29ab31337e61/45a09c1f-9b5f-448f-a816-29ab31337e61.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/45a09c1f-9b5f-448f-a816-29ab31337e61/45a09c1f-9b5f-448f-a816-29ab31337e61.vtt" type="text/vtt" language="en"/><itunes:author>Rohit Mehmi</itunes:author><itunes:subtitle>In Episode 2 of The Janus Pharma Insights, we explore Vonoprazan — a potassium-competitive acid blocker (P-CAB) offering fast, lasting relief for GERD, reflux esophagitis, and peptic ulcers. We look at why it's gaining traction with healthcare...</itunes:subtitle><itunes:summary><![CDATA[In Episode 2 of The Janus Pharma Insights, we explore Vonoprazan — a potassium-competitive acid blocker (P-CAB) offering fast, lasting relief for GERD, reflux esophagitis, and peptic ulcers. We look at why it's gaining traction with healthcare providers and how Janus Biotech supplies high-grade Vonoprazan 10 mg and 20 mg tablets to distributors and pharmacies across India. Looking for a reliable supply partner? Visit janus.co.in to learn more.<br />🔗 Read more: <a href="https://janus.co.in/product/vonoprazan-20-mg-10mg/" target="_blank" rel="noreferrer noopener">https://janus.co.in/product/vonoprazan-20-mg-10mg/</a>]]></itunes:summary><itunes:duration>57</itunes:duration><itunes:keywords>gastrohealth,janusbiotech,pharmadistribution,vonoprazan</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>The Rise of Niacinamide Serum Manufacturing in India - Podcast</title><link>https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452</link><description><![CDATA[In this episode of The Janus Pharma Insights, we explore the rise of <a href="https://janus.co.in/niacinamide-serum-manufacturers/" target="_blank" rel="noreferrer noopener"><b>niacinamide serum manufacturing in India</b></a> and why skincare brands are rapidly investing in niacinamide-based products. From growing consumer awareness and dermatologist-backed skincare trends to private label cosmetic manufacturing and third-party serum production, this podcast discusses the factors driving demand in the Indian skincare industry.<br /><br />Listen to insights on niacinamide serum manufacturing, cosmetic manufacturing in India, private label skincare products, serum formulation trends, and the growing business opportunities in the skincare market. This episode also highlights how skincare brands are partnering with experienced cosmetic manufacturers for scalable and quality-focused serum production.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/72202452</guid><pubDate>Thu, 28 May 2026 07:25:16 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/72202452/the_rise_of_niacinamide_serum_manufacturing_in_india_podcast.mp3" length="2602567" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/fcad018c-de0b-498d-9ae9-d6537d572cae/fcad018c-de0b-498d-9ae9-d6537d572cae.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/fcad018c-de0b-498d-9ae9-d6537d572cae/fcad018c-de0b-498d-9ae9-d6537d572cae.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/fcad018c-de0b-498d-9ae9-d6537d572cae/fcad018c-de0b-498d-9ae9-d6537d572cae.vtt" type="text/vtt" language="en"/><itunes:author>Rohit Mehmi</itunes:author><itunes:subtitle>In this episode of The Janus Pharma Insights, we explore the rise of https://janus.co.in/niacinamide-serum-manufacturers/ and why skincare brands are rapidly investing in niacinamide-based products. From growing consumer awareness and...</itunes:subtitle><itunes:summary><![CDATA[In this episode of The Janus Pharma Insights, we explore the rise of <a href="https://janus.co.in/niacinamide-serum-manufacturers/" target="_blank" rel="noreferrer noopener"><b>niacinamide serum manufacturing in India</b></a> and why skincare brands are rapidly investing in niacinamide-based products. From growing consumer awareness and dermatologist-backed skincare trends to private label cosmetic manufacturing and third-party serum production, this podcast discusses the factors driving demand in the Indian skincare industry.<br /><br />Listen to insights on niacinamide serum manufacturing, cosmetic manufacturing in India, private label skincare products, serum formulation trends, and the growing business opportunities in the skincare market. This episode also highlights how skincare brands are partnering with experienced cosmetic manufacturers for scalable and quality-focused serum production.]]></itunes:summary><itunes:duration>161</itunes:duration><itunes:keywords>cosmeticmanufacturing,niacinamideserum,niacinamideserummanufacturing,privatelabelskincare,skincareindustryindia,thirdpartycosmeticmanufacturin</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/773787161fe462aa98e30074a9f53eee.jpg"/><itunes:episodeType>full</itunes:episodeType></item></channel></rss>
